Brief: Expanded FDA Market Approval For OssDsign Catalyst

OssDsign AB

18/09/2023 08:18

Sept 18 (Reuters) - OssDsign AB  OSSD.ST :
    * OSSDSIGN CATALYST GETS EXPANDED MARKET APPROVAL FROM FDA FOR SIGNIFICANT NEW INDICATION
FOR USE
IN SPINAL CAGES

Source text for Eikon:  ID:nWkr4d8D9f 
Further company coverage:  OSSD.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))